Stocklytics Platform
Asset logo for symbol OGN
Organon & Co.
OGN65
$14.62arrow_drop_down1.77%-$0.26
Asset logo for symbol OGN
OGN65

$14.62

arrow_drop_down1.77%
Key Stats
Open$14.90
Prev. Close$14.89
EPS5.05
Next Earnings DateMar 13, 2025
LOWHIGH
Day Range14.53
14.98
52 Week Range10.83
23.10
Ratios
Revenue-
EPS5.05
Fundamentals
Industry average yield3.18%
Last Dividend pay dateDec 12, 2024

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

OGN-
US Healthcare Sector-
US Market-
warning

OGN / Market

OGN lose to the US Market which returned -0.68% over the last twenty four hours.
warning

OGN / Healthcare Sector

OGN lose to the US Healthcare sector which returned 1.01% over the last twenty four hours.

Organon & Co. (OGN) Statistics

Organon & Co. (OGN) is a leading global healthcare company that specializes in the development, manufacturing, and distribution of innovative pharmaceutical products. With a strong focus on women's health and oncology, Organon & Co. is dedicated to improving the lives of patients around the world. As of the latest available data, Organon & Co. has a market capitalization of $X billion, making it one of the largest companies in the healthcare sector.
When examining the valuation metrics of Organon & Co., several factors should be considered. First, the price-to-earnings ratio (P/E ratio) provides insight into the relative valuation of the company's stock. As of the most recent data, Organon & Co. has a P/E ratio of X, indicating that the stock may be undervalued or overvalued compared to its industry peers. Another important metric is the price-to-sales ratio (P/S ratio), which measures the company's market capitalization relative to its total revenue. Organon & Co. has a P/S ratio of X, indicating that investors are willing to pay X times the company's annual revenue for each share of stock.
add Organon & Co. to watchlist

Keep an eye on Organon & Co.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Organon & Co. (OGN) stock's performance compared to its sector and the market over the past year?

Over the past year, Organon & Co. (OGN) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 18.95%, Organon & Co. has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 44.33%, it has fallen short of the market average. This comparison highlights Organon & Co.'s performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Organon & Co. (OGN) stock?

The PE (Price to Earnings) ratio of Organon & Co. (OGN) is currently 2.9. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Organon & Co. (OGN) stock?

The Earnings Per Share (EPS) for Organon & Co. (OGN), calculated on a diluted basis, is $5.05. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Organon & Co. (OGN) stock?

The operating margin for Organon & Co. (OGN) is 24.65%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Organon & Co. (OGN) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Organon & Co. (OGN) is $1.75B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Organon & Co. (OGN) have?

Organon & Co. (OGN) has a total debt of $8.75B. The net debt, which accounts for cash and cash equivalents against the total debt, is $7.99B.

Take Your Investments to a Whole New Level